
CAS 54494-34-7
:jolkinolide E
Description:
Jolkinolide E is a natural compound classified as a sesquiterpene lactone, primarily derived from certain plant species, particularly those in the Asteraceae family. It is characterized by its complex bicyclic structure, which contributes to its unique chemical properties and biological activities. The molecular formula of jolkinolide E reflects its composition of carbon, hydrogen, and oxygen atoms, typical of many terpenoids. This compound has garnered interest in the field of medicinal chemistry due to its potential anti-inflammatory, anti-cancer, and antimicrobial properties, making it a subject of various pharmacological studies. Its mechanism of action often involves modulation of cellular pathways, which can lead to apoptosis in cancer cells or inhibition of inflammatory mediators. Additionally, the compound's stability and solubility characteristics can influence its bioavailability and therapeutic efficacy. Research continues to explore the full range of biological activities and potential applications of jolkinolide E in drug development and natural product chemistry.
Formula:C20H28O2
Synonyms:- (4aR,10aR,11aR,11bR)-4,4,8,11b-tetramethyl-2,3,4a,5,6,10a,11,11a-octahydro-1H-naphtho[2,1-f][1]benzofuran-9-one
- (4aR,10aR,11aR,11bR)-2,3,4,4a,5,6,10a,11,11a,11b-Decahydro-4,4,8,11b-tetramethyl-phenanthro[3,2-b]furan-9(1H)-one
- jolkinolide E
- Phenanthro[3,2-b]furan-9(1H)-one, 2,3,4,4a,5,6,10a,11,11a,11b-decahydro-4,4,8,11b-tetramethyl-, (4aR,10aR,11aR,11bR)-
- Helioscopinolide G
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Jolkinolide E
CAS:Jolkinolide E is a natural product of Stellera, Thymelaeaceae.Formula:C20H28O2Purity:98%Color and Shape:SolidMolecular weight:300.44Jolkinolide E
CAS:Controlled Product<p>Jolkinolide E is a bioactive compound, which is a diterpenoid lactone derived from the plant Euphorbia fischeriana. This compound originates from a natural herbal source, known for its diverse biofunctional properties. Jolkinolide E's mode of action involves the modulation of inflammatory pathways, specifically by inhibiting key signaling proteins such as NF-κB, which plays a crucial role in inflammatory responses.<br><br>Jolkinolide E has garnered attention for its potential therapeutic applications. Studies have demonstrated its efficacy in reducing inflammation, making it a candidate for developing treatments for inflammatory diseases. Additionally, its anticancer potential has been explored, with research indicating its ability to induce apoptosis in certain cancer cell lines. The compound’s ability to interact with multiple cellular targets positions it as a significant focus for further pharmaceutical research and development. Overall, Jolkinolide E serves as an intriguing compound warranting further exploration in the fields of pharmacology and medicinal chemistry.</p>Formula:C20H28O2Purity:Min. 95%Molecular weight:300.4 g/mol




